Physician profile
Peter J Schultz
NPI 1851409098
$2,383.48
in general payments reported to CMS, 2019-2025
18 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $239 · 2021: $451 · 2022: $548 · 2023: $571 · 2024: $296 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $985.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,245.67 | 2019-2025 | Proclaim, Eterna |
| Medtronic, INC. | $593.45 | 2021-2025 | Intellis Adaptivestim, Aquamantys(Tm) |
| Nalu Medical, INC. | $126.77 | 2022-2023 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $80.54 | 2019-2020 | |
| Nevro Corp. | $61.35 | 2019-2023 | Senza |
| Collegium Pharmaceutical, INC. | $51.91 | 2024-2025 | Belbuca |
| Tersera Therapeutics LLC | $30.68 | 2020-2021 | |
| Biotronik Nro, INC. | $27.74 | 2025 | Prospera |
| Mdd US Operations, LLC | $26.51 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $25.58 | 2019-2021 | |
| Grt US Holding, INC. | $17.97 | 2021 | |
| Ironshore Pharmaceuticals INC. | $17.82 | 2019 | |
| Vertos Medical, INC. | $17.56 | 2024 | Mild Device Kit |
| Biohaven Pharmaceuticals, INC. | $13.55 | 2021 | |
| Amgen INC. | $12.65 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $11.44 | 2019 | |
| Abbvie INC. | $11.23 | 2021 | |
| Biodelivery Sciences International, INC. | $11.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.